LLY

744.38

-1.95%↓

JNJ

154.8

-0.78%↓

UNH

380.03

-1.9%↓

ABBV

186.95

+0.65%↑

ABT

134.06

-0.45%↓

LLY

744.38

-1.95%↓

JNJ

154.8

-0.78%↓

UNH

380.03

-1.9%↓

ABBV

186.95

+0.65%↑

ABT

134.06

-0.45%↓

LLY

744.38

-1.95%↓

JNJ

154.8

-0.78%↓

UNH

380.03

-1.9%↓

ABBV

186.95

+0.65%↑

ABT

134.06

-0.45%↓

LLY

744.38

-1.95%↓

JNJ

154.8

-0.78%↓

UNH

380.03

-1.9%↓

ABBV

186.95

+0.65%↑

ABT

134.06

-0.45%↓

LLY

744.38

-1.95%↓

JNJ

154.8

-0.78%↓

UNH

380.03

-1.9%↓

ABBV

186.95

+0.65%↑

ABT

134.06

-0.45%↓

Search

OrthoPediatrics Corp

Aperta

SettoreSettore sanitario

22.6 -2.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

22.53

Massimo

23.46

Metriche Chiave

By Trading Economics

Entrata

-8.2M

-16M

Vendite

-1.9M

53M

EPS

-0.29

Margine di Profitto

-30.511

Dipendenti

562

EBITDA

-7.6M

-11M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+62.94% upside

Dividendi

By Dow Jones

Utili prossimi

4 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-37M

523M

Apertura precedente

24.89

Chiusura precedente

22.6

Notizie sul Sentiment di mercato

By Acuity

16%

84%

23 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

OrthoPediatrics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

8 mag 2025, 23:59 UTC

Notizie principali
Utili

Naver 1Q Net Slumps on Higher Costs

8 mag 2025, 23:39 UTC

Utili

OCBC 1Q Net Down on Lower Interest Income

8 mag 2025, 23:01 UTC

Utili

Macquarie Raises Dividend After 5.5% Rise in Annual Profit -- Update

8 mag 2025, 22:52 UTC

Utili

REA Expects Annual Listings Growth Despite April Decline

8 mag 2025, 22:46 UTC

Utili

Macquarie Raises Dividend After 5.5% Rise in Annual Profit

8 mag 2025, 23:45 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

8 mag 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Rise as Tariffs Fears Ease -- Market Talk

8 mag 2025, 23:41 UTC

Discorsi di Mercato

Gold Rises on Possible Technical Recovery; Gains May be Capped by Risk-on Mood -- Market Talk

8 mag 2025, 23:30 UTC

Utili

Itau Unibanco 1Q Rev BRL45.02B >ITUB

8 mag 2025, 23:29 UTC

Utili

Itau Unibanco 1Q EPS BRL1.03 >ITUB

8 mag 2025, 23:22 UTC

Utili

Naver 1Q Net Profit Largely Met FactSet-Compiled Consensus

8 mag 2025, 23:22 UTC

Utili

Naver 1Q Net KRW423.70B Vs. Net KRW555.80B >035420.SE

8 mag 2025, 23:21 UTC

Utili

Naver 1Q Oper Pft KRW505.30B Vs. Pft KRW439.30B >035420.SE

8 mag 2025, 23:21 UTC

Utili

Naver 1Q Rev KRW2.787T Vs. KRW2.526T >035420.SE

8 mag 2025, 23:17 UTC

Utili

Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.35B Vs. S$2.44B >O39.SG

8 mag 2025, 23:17 UTC

Utili

Oversea-Chinese Banking Corp. 1Q Total Income S$3.66B Vs. S$3.63B >O39.SG

8 mag 2025, 23:17 UTC

Utili

Oversea-Chinese Banking Corp. 1Q Net S$1.88B Vs. Net S$1.98B >O39.SG

8 mag 2025, 23:05 UTC

Discorsi di Mercato

ANZ Could Cut Dividend by 10% From 2H -- Market Talk

8 mag 2025, 23:05 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

8 mag 2025, 23:01 UTC

Notizie principali

With U.K. Deal, U.S. Signals That 10% Tariff on World Is New Baseline -- WSJ

8 mag 2025, 22:28 UTC

Utili

REA Expects FY 2025 Listings Growth of 1-2%

8 mag 2025, 22:28 UTC

Utili

REA Says April Listings Decline Reflects Year Ago Strength, Timing of Easter and Election

8 mag 2025, 22:27 UTC

Utili

REA Says April Sydney, Melbourne Listings Both Down 16% on Year

8 mag 2025, 22:27 UTC

Utili

REA Says April Residential Listings Fell by 11% on Year

8 mag 2025, 22:26 UTC

Utili

REA 3Q Operating Expenses A$176 Million, Up 12% on Year

8 mag 2025, 22:26 UTC

Utili

REA 3Q Free Cash Flow A$132 Million, Up 19% on Year

8 mag 2025, 22:26 UTC

Utili

REA 3Q Operating Ebitda A$199 Million, Up 12% on Year

8 mag 2025, 22:26 UTC

Utili

REA Nine-Months Free Cash Flow A$389 Million, Up 21% on Year

8 mag 2025, 22:25 UTC

Utili

REA Nine-Months Operating Expenses A$513 Million, Up 15% on Year

8 mag 2025, 22:25 UTC

Utili

REA Nine-Months Operating Ebitda A$734 Million, Up 19% on Year

Confronto tra pari

Modifica del prezzo

OrthoPediatrics Corp Previsione

Obiettivo di Prezzo

By TipRanks

62.94% in crescita

Previsioni per 12 mesi

Media 36.14 USD  62.94%

Alto 50 USD

Basso 24 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per OrthoPediatrics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

7 ratings

6

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.36 / N/ASupporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

23 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo OrthoPediatrics Corp

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.